Rockwell Medical

$1.24
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.10 (-7.52%) Today
+$0.01 (+0.81%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell RMTI and other stocks, options, and ETFs commission-free!

About RMTI

Rockwell Medical, Inc. (DE) Common Stock, also called Rockwell Medical, is a biopharmaceutical company, which engages in the development of treatment for anemia, kidney disease, iron deficiency, and hemodialysis. Its products include Triferic, CitraPure, RenalPure and SteriLyte. The company was founded by Robert L. Chioini in January 1995 and is headquartered in Wixom, MI. The listed name for RMTI is Rockwell Medical, Inc. (DE) Common Stock.

CEO
Russell H. Ellison
Employees
299
Headquarters
Wixom, Michigan
Founded
1995
Market Cap
108.66M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.71M
High Today
$1.36
Low Today
$1.17
Open Price
$1.32
Volume
2.50M
52 Week High
$3.85
52 Week Low
$0.83

RMTI Earnings

-$0.17
-$0.11
-$0.06
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 11, After Hours

You May Also Like

CRZBY
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure